 - Patients with relapsedrefractory acute myelogenous leukemia AML, poor risk myelodysplastic syndrome MDS, B-cell acute lymphocytic leukemia ALL, myeloproliferative diseases, or chronic myelogenous leukemia CML in blast crisis 